Logo

PharmaShots Weekly Snapshots (October 25 - 29, 2021)

Share this

PharmaShots Weekly Snapshots (October 25 - 29, 2021)

ADC Reports EMA's Validation of MAA for Zynlonta to Treat R/R Diffuse Large B-Cell Lymphoma

Published: Oct 29, 2021 | Tags: ADC, EMA, MAA, Zynlonta, R/R Diffuse Large B-Cell Lymphoma

Impact Receives US FDA's IND Clearance for IMP9064 to Treat Solid Tumor

Published: Oct 29, 2021 | Tags: Impact, US, FDA, IND, IMP9064, Solid Tumor

Novartis Reports the US FDA and EMA's Acceptance of sBLA for Kymriah (tisagenlecleucel) and Granted Priority Review to Treat R/R Follicular Lymphoma

Published: Oct 29, 2021 | Tags: Novartis, US, FDA, EMA, sBLA, Kymriah, Tisagenlecleucel, Priority Review, R/R Follicular Lymphoma

AbbVie Reports Results of ABBV-951 (foslevodopa/foscarbidopa) in P-III M15-736 Study for the Treatment of Advanced Parkinson's Disease

Published: Oct 29, 2021 | Tags: AbbVie, ABBV-951, foslevodopa, foscarbidopa, P-III, M15-736 Study, Advanced Parkinson's Disease

Kite's Tecartus (brexucabtagene autoleucel) Receives Health Canada's Approval for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Published: Oct 29, 2021 | Tags: Kite, Tecartus, brexucabtagene autoleucel, Health Canada, Approval, Mantle Cell Lymphoma

Incyte Reports EMA's Validation of MAA for Ruxolitinib Cream to Treat Vitiligo

Published: Oct 29, 2021 | Tags: Incyte, EMA, MAA, Ruxolitinib Cream, Vitiligo

Immunic Reports Completion of Patient Enrollment in P-II CALDOSE-1 Trial of IMU-838 for the Treatment of Ulcerative Colitis

Published: Oct 28, 2021 | Tags: Immunic, P-II, CALDOSE-1 Trial, IMU-838, Ulcerative Colitis

Hutchmed Initiates P-III ESLIM-01 Trial of HMPL-523 for the Treatment of Immune Thrombocytopenia in China

Published: Oct 28, 2021 | Tags: Hutchmed, P-III, ESLIM-01 Trial, HMPL-523, Immune Thrombocytopenia, China

Innovent Entered into a Collaboration Agreement with NeoCura to Evaluate Sintilimab + NEO_PLIN2101 for Cancer in China

Published: Oct 28, 2021 | Tags: Innovent, NeoCura, Sintilimab, NEO_PLIN2101, Cancer, China

Alnylam Reports Results of Vutrisiran in P-III HELIOS-A Study for the Treatment of hATTR Amyloidosis with Polyneuropathy

Published: Oct 28, 2021 | Tags: Alnylam, Vutrisiran, P-III, HELIOS-A Study, hATTR Amyloidosis, Polyneuropathy

Curacle Signs a License and Collaboration Agreement with Théa for Development and Commercialization of CU06-RE to treat Diabetic Macular Edema and Wet-AMD

Published: Oct 28, 2021 | Tags: Curacle, Théa, CU06-RE, Diabetic Macular Edema, Wet-AMD

Takeda to Acquire GammaDelta to Advance the Development of Allogeneic 'dT Cell Therapies for the Treatment of Solid Tumors

Published: Oct 28, 2021 | Tags: Takeda, GammaDelta, Allogeneic ?dT Cell Therapies, Solid Tumors

Merck Presents Results of Islatravir + Doravirine in P-IIb Clinical Trial for the Treatment of HIV-1 at EACS 2021

Published: Oct 27, 2021 | Tags: Merck, Islatravir, Doravirine, P-IIb, Clinical Trial, HIV-1, EACS 2021

Teva Signs an Exclusive WW License Agreement with Modag to Develop Anle138b and Sery433 for Neurodegenerative Disease

Published: Oct 27, 2021 | Tags: Teva, Modag, Anle138b, Sery433, Neurodegenerative Disease

Vifor and Angion's ANG-3777 Fail to Meet its Primary and Secondary Endpoint for Patients with High-Risk Kidney Transplant

Published: Oct 27, 2021 | Tags: Vifor, Angion, ANG-3777, High-Risk Kidney Transplant,Delayed Graft Function

Pfizer and BioNTech's COVID-19 Vaccine Receive the US FDA's Advisory Committee Vote Supporting EUA Against COVID-19

Published: Oct 27, 2021 | Tags: Pfizer, BioNTech, COVID-19 Vaccine, US, FDA, Advisory Committee, EUA, COVID-19

Selecta Collaborates with Ginkgo to Develop Therapeutic Enzymes for the Treatment of Orphan and Rare Diseases

Published: Oct 27, 2021 | Tags: Selecta, Ginkgo Bioworks, Orphan, Rare Diseases, Therapeutic Enzymes

Vertex Collaborates with Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Diseases

Published: Oct 27, 2021 | Tags: Vertex, Mammoth Biosciences, In Vivo Gene-Editing Therapies, Genetic Diseases

Moderna Reports Results of COVID-19 Vaccine in P-II/III KidCOVE Study for the Treatment of COVID-19

Published: Oct 26, 2021 | Tags: Moderna, COVID-19 Vaccine, mRNA-1273, P-II/III, KidCOVE Study, COVID-19

Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India

Published: Oct 26, 2021 | Tags: Glenmark, Remogliflozin, Vildagliptin, Metformin, Type 2 Diabetes, India

Guardant Health Presents Results of LUNAR-2 Blood Test for the Treatment of Early-Stage Colorectal Cancer at ACG 2021

Published: Oct 26, 2021 | Tags: Guardant Health, LUNAR-2 Blood Test, Early-Stage Colorectal Cancer, ACG 2021

MSD Entered into a Clinical Trial Collaboration with Evaxion to Evaluate EVX-01 + Keytruda (pembrolizumab) for Metastatic Melanoma

Published: Oct 26, 2021 | Tags: MSD, Evaxion, EVX-01, Keytruda, pembrolizumab, Metastatic Melanoma

AstraZeneca Reports Results of Imfinzi in P-III TOPAZ-1 Trial as 1L Treatment for Advanced Biliary Tract Cancer

Published: Oct 26, 2021 | Tags: AstraZeneca, Imfinzi, P-III, TOPAZ-1 Trial, Advanced Biliary Tract Cancer

Daiichi Sankyo and AstraZeneca Entered into a Second Clinical Trial Collaboration with Merck for Datopotamab Deruxtecan (Dato-DXd) + Keytruda (pembrolizumab)

Published: Oct 26, 2021 | Tags: Daiichi Sankyo, AstraZeneca, Merck, Datopotamab Deruxtecan, Dato-DXd, Keytruda, pembrolizumab, Metastatic NSCLC

Merck Reports Results of Doravirine/Islatravir as Fixed Dose Combination in P-III Trials for the Treatment of HIV-1 Infection

Published: Oct 25, 2021 | Tags: Merck, Doravirine, Islatravir, Fixed Dose Combination, P-III, Trials, HIV-1 Infection

Merck and Ridgeback Report the Initiation of EMA Rolling Review of Molnupiravir for the Treatment of COVID-19

Published: Oct 25, 2021 | Tags: Merck, Ridgeback, EMA, Molnupiravir, COVID-19

Novartis Reports Results of Canakinumab in P-III CANOPY-1 Study for the Treatment of Lung Cancer

Published: Oct 25, 2021 | Tags: Novartis, Canakinumab, P-III, CANOPY-1 Study, Lung Cancer

Regeneron and Sanofi Report Results of Dupixent (dupilumab) in P-III Trial for the Treatment of Eosinophilic Esophagitis

Published: Oct 25, 2021 | Tags: Regeneron, Sanofi, Dupixent, dupilumab, P-III, Trial, Eosinophilic Esophagitis

Agenus Reports the Withdrawal of BLA for Balstilimab to Treat Cervical Cancer

Published: Oct 25, 2021 | Tags: Agenus, Withdrawal, BLA, Balstilimab, Cervical Cancer

Genentech's Susvimo Receives the US FDA's Approval for the Treatment of Wet Age-Related Macular Degeneration

Published: Oct 25, 2021 | Tags: Genentech, Susvimo, US, FDA, Approval, Wet Age-Related Macular Degeneration

Related Post: PharmaShots Weekly Snapshots (October 18 - 22, 2021)


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions